Preservatives in eyedrops: the good, the bad and the ugly.
Baudouin
Christophe
C
Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, INSERM, U968, UPMC Univ Paris 06, UMR_S 968, Institut de la Vision, CNRS, UMR_7210, Paris F-75012, France. baudouin@quinze-vingts.fr
Labbé
Antoine
A
Liang
Hong
H
Pauly
Aude
A
Brignole-Baudouin
Françoise
F
D000818:Animals; D001548:Benzalkonium Compounds / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use; D015352:Dry Eye Syndromes / Q000188:drug therapy; D005128:Eye Diseases / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D008954:Models, Biological; D009883:Ophthalmic Solutions / Q000009:adverse effects*; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D013666:Tears / Q000187:drug effects
D001548:Benzalkonium Compounds; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical